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Abstract
A paradox of so-called developed countries is that, as the major historical causes of human 
mortality are eliminated or mitigated by medical progress, life-style related diseases have become 
major killers. Furthermore, as life-span is extended by the combined effects of modern medicine, 
health-span is struggling to keep apace because of the burden of non-communicable diseases 
linked to diet and sedentary life-style. The gut microbiome is now recognized as a plastic 
environmental risk factor for many of these diseases, the microbiome being defined as the 
complex community of co-evolved commensal microbes that breaks down components of a 
complex diet, modulates innate immunity, and produces signalling molecules and metabolites that 
can impact on diverse regulatory systems in mammals. Aspects of the so-called “Western” life-
style linked to disease risk such as energy dense diet and antibiotic treatment are known to affect 
the composition and function of the microbiome. Here we review the detailed mechanisms 
whereby the gut microbiome may modulate risk of diseases linked to sedentary life-style, and 
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hibernation for studying metabolic regulation, and the challenge of extrapolating from animal 
models to processes that occur in human ageing.
Introduction to the mammalian microbiome 
The term “microbiome” refers to the collection of microbes and their genes that is present as a 
community in a given location [1]. Some authors used the term “microbiota” to describe the 
microbes themselves, and “microbiome” to refer to their genes or collective coding capacity. The 
last decade has witnessed a dramatic surge in the application of microbiome studies across a wide 
range of fields, from environmental science, through to medicine and industrial microbiology. This 
is because modern tools in molecular biology and high-throughput sequencing have 
revolutionized the depth and precision with which complex microbial communities can be 
forensically studied [2]. Many of these tools were developed for environmental microbiology, 
where it has always been appreciated that complex communities of microbes that are hard to 
culture in the laboratory are often present. Human and animal body sites provide complex growth 
substrates to nutritionally fastidious microbes, which makes it hard to replicate these growth 
conditions in the laboratory, and many of these microbes were thought to be unculturable on 
laboratory media, but this has been disproved in recent years [3, 4]. Nevertheless, a major driving 
factor in the development and dissemination of microbiome technology was the ability to 
routinely and affordably catalogue the composition of the microbiome in a given location, and to 
study its correlation with states or traits. There are a diversity of ways to study the microbiome 
(summarized in Figure 1) that afford insights into what the bacterial community might do (its total 
coding capacity), the range of metabolites it produces (the metabolome), and the total 
complement of proteins detectable in a given sample (the metaproteome). 
The pioneering studies in mammalian microbiome science were performed on humans, 
and a major focus was on the gut microbiome, which harbours one of the largest bacterial loads, 
and one of the most diverse bacterial communities [5]. In fact, the gut microbiome contains 
bacteria, fungi (mycobiome), eukaryotic viruses (virome), prokaryotic viruses (phageome), and 
protozoa, with most studies to date focussing on the bacterial component. The  ELDERMET [8] 
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exist in which large numbers of standardized microbiome datasets from cases and controls are 
archived and which may be downloaded, facilitating comparative analysis [9]. 
Establishing what microbes are present in a biological sample can be performed quickly 
and cheaply by sequencing ribosomal RNA (rRNA) gene amplicons, whereas determining what 
functions these microbes encode requires true metagenomics, meaning shotgun sequencing of 
total community DNA [10]. Many of the early differences between microbiome datasets were due 
to technical variation in sampling, DNA extraction and preparation for DNA sequencing, a 
challenge in standardization that has been resolved through international collaborative effort to 
establish robust protocols [11].
The microbiome in human health and disease 
The history of the discipline of microbiology was driven to a large degree by the need to 
understand microbes as pathogens, an endeavour that has encompassed some of the biggest 
milestones in the development of the scientific method [12]. The concept that microorganisms 
may be beneficial is also over a century old [13] but received relatively little attention until the late 
20th century, when the beneficial effect of deliberately consumed single strains (probiotics) gained 
scientific and commercial traction [14]. A broad range of beneficial effects have been reported for 
probiotics but only a few mechanisms have been proven in humans, and even fewer claims 
granted regulatory approval [15]. The technical developments described above, that made 
identifying microbiome composition and function routine and affordable, facilitated a multitude of 
studies comparing the gut microbiome in various diseases and syndromes with that of healthy 
controls [16]. The core logic that these studies pivot upon is that the gut microbiome of an animal 
has co-evolved with that host species; that the microbiome provides a number of key functions 
including metabolism, innate immunity and colonization resistance; that deviations from 
harbouring the normal core microbiome to harbouring an altered microbiome (sometimes called 
dysbiosis [17]) associate robustly with particular diseases because of the loss of the relevant 
microbes [18]. The bidirectional interactions of the gut microbiome with external life-style factors 
which impact on it, as well as host physiological systems that the microbiome itself impacts upon, 
are summarized graphically in Figure 2. These effects are not all intestinal or metabolic; the gut 
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effect on circulating neuroactive metabolites that bacteria either produce or deplete [19]. It 
logically follows on from these microbiome-disease associations that all patients suffering from 
the same microbiome-related disease should show a shared disease signature in their 
microbiome; that the altered functional properties of the microbiome should explain the 
mechanism of disease causation; that the disease may be rectifiable by providing the missing 
elements of the altered microbiome, or by repressing over-abundant microbes. The functions 
commonly associated with the gut microbiota, and the disease indications that arise when the 
microbiome is perturbed, have recently been reviewed [20]. Studies of microbiome disease 
associations are complicated by confounding factors that impact the microbiome (Figure 2) such 
as habitual diet [21, 22], antibiotics [23], medications [24], genetics [25] and geographical region 
[26]. It also appears that many diseases involving microbiome alteration share similarly altered 
microbiome signatures, and that only a small proportion of changes in the microbiome are 
actually disease specific [27]. Despite these challenges, microbiome research has underpinned a 
new wave of commercial endeavour aimed at developing taxa whose abundance is altered in 
particular conditions or diseases as Live Biotherapeutics [28].
Comparative analyses of human and animal microbiomes 
Germ-free animals display a number of physiological, behavioural, immunological and metabolic 
impairments [29, 30], which support the notion that mammals and their microbiomes co-evolved 
in a symbiotic or mutualistic fashion [18]. Comparison of the composition and function of animal 
microbiomes could therefore elucidate the bacterial taxa and their functions involved in critical 
microbiome functions in particular mammalian hosts. These investigations confirmed that the 
relatedness of gut microbial communities in animals mirrored the phylogeny of the host organism 
but that diet patterns were very important, with the microbiome diversity of herbivores being 
much greater than that of omnivores or carnivores [31]. The bacterial relatedness networks were 
very concordant whether built upon the microbial taxa defined by ribosomal RNA genes or 
genome-wide coding capacity, showing that the metabolic functions also co-evolved with the 
animal host [32]. This prompted a re-appraisal of animal models for studying human gut 
microbiome-related traits, and the limitations of rodent models that display very different 
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microbiome and are central to microbiome-host interactions, being used as an energy source for 
enterocytes, modulating host epithelial barrier function, proliferation and metabolism [33]. The 
major differences in the composition of the gut microbiome of humans compared to mice, rats 
and non-human primates are also reflected in the relative abundance of the major short-chain 
fatty acid levels in these hosts [34], underscoring the caution required when using animal models 
for studying primate traits. In large-scale comparison, both diet and body size affect microbiome 
diversity in the gut but gut physiology (fermenter versus simple stomach physiology) is the most 
important driver [35]. As a further caveat to be borne in mind when exploiting microbiome-
mammal host co-evolution, a recent study demonstrated a discordance between gut microbiome 
composition and evolutionary history in primates, whereby the microbiome of humans consuming 
non-industrialized diets and monkeys subsisting on eclectic, omnivorous diets were more similar 
that other human-primate comparisons [36].
The ageing process 
In recent times, ageing has been increasingly viewed as a collection of morbidities in the final 
decades of life that can be treated like a disease. Ageing, however, is more appropriately 
described as a process during which an accumulation of deficits takes place over the entire life-
course [37]. It comprises a segmental and progressive loss of physiological function and physical 
capability over time, manifesting as a loss of physiological resilience and resultant frailty. It 
represents a dynamic interaction between an individual’s genome, epigenome and exposome (i.e. 
social and  psychological factors, nutrition, lifestyle and physical environment). Intuitively, this 
results in substantial interindividual variation in how we age and makes defining normative ageing 
difficult [38]. At a metabolic level it results in a general impairment of anabolic pathways and 
activation of catabolic pathways [39].
Features of ageing have been hallmarked to exemplify commonality across taxa [40], and 
accelerated biological ageing (i.e.‘miles on the clock’) is a feature of age-related morbidities that 
comprise a ‘diseasome of ageing’ [41]. In particular, dysregulated nutrient sensing is a hallmark of 
ageing, where epigenetic regulation of nutrient sensing pathways and nutritional differences tied 
to socioeconomic factors, show differential effects of the exposome on features of human ageing, 
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shares common features, including persistent low-grade inflammation, hyperphosphataemia, 
depressed Nrf2 activity, depleted metabolic capability, depressed mitochondrial biogenesis and 
alterations in the gut microbiome [39, 41]. These interactions are graphically summarized in Figure 
3.
Of note, mammalian longevity shows a strong negative correlation with nutritionally acquired 
serum phosphate levels [44, 45]. Indeed, human progerias, such as Hutchinson’s Guilford’s 
Syndrome, or a disease of accelerated ageing, such as CKD, display elevated serum phosphate 
levels [44]. Epidemiological studies have indicated that frequent consumption of red meat is a 
source of age-related hyperphosphataemia in man [46]. This offers a mechanistic basis for age 
related health, inflammatory burden (inflammageing) and alterations in the composition and role 
of the microbiota. Red meat also contains carnitine, a substrate for production of the highly pro-
atherogenic trimethylamine N-oxide (TMAO) from trimethylamine (TMA).  Gut microbial enzymes 
are required for TMA production. TMAO, produced from TMA by liver enzymes,  has been 
implicated in both ageing and mortality across a spectrum of age related disease [47-49] and may 
link read meat to mortality [50]. By extension, this is also pertinent to the relationship between 
inflammation and cancer. A pro-inflammatory phenotype is a feature of advanced biological 
ageing and associated with a range of cancers, in particular colorectal cancer [51]. Typically, this 
has been attributed to the production of a pro-inflammatory senescence associated secretory 
phenotype (SASP). Tumourigenesis, however, may be driven by an inflammatory 
microenvironment, even in the absence of overt inflammation. There is also a further emerging 
role for the microbiome in modulating both  local and systemic inflammatory burden. Significantly, 
while the gut microbiome can contribute directly to the generation of pro inflammatory 
metabolites such as TMA, dysbiosis can lead to a reduction of butyrate production BORREL. 
Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome. 
The ISME journal 11: 2059). A reduction in such short chain fatty acid  production can exacerbate 
inflammation and contribute to cancer progression by epigenetic dysregulation through microbial 
production of butyrate [52]. Notably, inclusion of more plant based protein into the diet has been 
reported to reduce systemic inflammatory burden and  the incidence of both cancer and CVD 
related deaths [53]. This is supported by studies from the UK Biobank indicating an elevated risk of 
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determined how TMAO interplays with the exposome in normative ageing, though it is intuitive to 
predict that it will show dynamic interaction with the age-related microbiome.
While a link between food and health and longevity has been described from the time of 
the Celts and the mythical healing cauldron of An Dagda, through to the Corpus Hippocraticum of 
the Classical world, it regained attention in the early 20th century with studies on dietary 
restriction. The relationship appears both bi-directional and complex. Dietary restriction, for 
example, has repeatedly been demonstrated to improve health span and life span in pre-clinical 
models [55]. Critically, genetic heterogeneity appears to play a determinant factor in the 
effectiveness of such interventions [56], though the mechanistic basis is not well determined. The 
impact of epigenetic heterogeneity is still subject to intensive investigation [57].
Nutrition may also impact on the epigenetic landscape of ageing via the availability and 
provision of methyl donors for maintenance of the methylome [58]. This is consistent with reports 
indicating an imbalanced diet and low intake of fruit and vegetables correlates with genomic 
hypomethylation and accelerated biological ageing [59]. Additionally, recent observations have 
associated this with alterations in the microbiome (Craven and Shiels, in prep.). The impact of 
nutritional composition and metabolic sequalae influenced by the gut microbiome is an 
underpinning feature of metabolism across taxa and may even determine the relationship 
between energy storage and body mass [60].
Lack of dietary fruit and vegetable intake also provides a direct link to the production of 
alkyl catechols from dietary derived phenolic acids. Alkyl catechols production requires gut 
microbes and as such links microbial activity to cellular stress defences [61]. Significantly, alkyl 
catechols are potent Nrf2 agonists. Nrf2 regulates over 390 stress defence genes linked to 
longevity and health span. Moreover, alkyl catechols comprise a group of chemicals that include 
the senolytic agents fisetin and quercetin, which have proven efficacy in increasing lifespan and 
health span in mice [62].
The microbiome and ageing in Homo sapiens and in animals
Humans are born devoid of microbes, and neonates undergo a process of colonization in the early 
months of life that is marked by successive rounds of succession and extinction [63], finally 
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whether or not the infant was breast-fed, and at what age they were weaned [64, 65]. The healthy 
adult gut microbiota is individual-specific at strain level and stable over time, insofar as an 
individual subject’s microbiome remains more similar to itself over time than it does to other 
subjects [66]. However, many studies have independently reported that the microbiome 
undergoes changes as a function of age [67-70], and we have shown that this age-related 
microbiome change is accelerated when it accompanies frailty, especially when promoted by 
consumption of a restricted diet [71-73]. Notably, a study of >1,000 subjects in China revealed 
very little difference of the microbiome in older subjects, perhaps because they were 
exceptionally healthy, lived in a single region, and ate a very similar diet [74]. Although lower 
levels of global microbiome diversity (alpha diversity) are common of older people, there is no 
threshold age at which this decline begins, and moving from a healthy high-diversity microbiome 
state to a frail low-diversity state may pass through an intermediate state of even higher diversity 
[71]. However, when subjects’ microbiome were profiled longitudinally, temporal instability was 
more pronounced in subjects with low initial microbiota diversity [71]. Changes in the functional 
capacity of older subjects include loss of short chain fatty acid production associated with frailty 
[75, 76], increased tryptophan metabolism associated with reduced cognitive function in some 
centenarians [70], and higher levels of some methanogenic archaea that may protect against 
atherosclerosis in some older people [77]. The gut microbiome has been mooted as a target for 
improving health in older people [78]. However, until it has been definitely proven that restoring 
the gut microbiota of older people improves health or slows health loss, it is prudent to treat it for 
now as an environmental modifier of phenotype in a multifactorial disease process.
Relatively few studies have examined the microbiome of older animals, probably because 
laboratory animals are expensive to house, and in older life they often suffer high rates of disease 
associated with in-breeding and loss of heterozygosity. Studies in our laboratory of rats up to two 
years of age showed clear age-related microbiome alteration and increase in alpha diversity [79], 
with an increase in short-chain fatty acid production that contrasted with the decline in frail older 
human subjects [69]. Older mice also have a different gut microbiome to older mice, and 
interestingly, co-housing or fecal transfer from adult to aged mice alters microbiome and boosts 
germinal centre response [80]. The altered gut epithelial gene expression pattern of older mice 
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abundance of so-called pathobionts, species such as Escherichia coli and other Proteobacteria that 
are opportunistic pathogens. Impaired gut barrier function in older mice (evidenced in the 
previous study by gene expression analysis) was corroborated in another group by leakage of 
fluorescent markers from the gut lumen into the blood, and this correlated with impaired 
cognitive function and an altered gut microbiome [82]. Collectively these studies show the 
potential usefulness of comparative physiology and microbiome science to develop hypotheses 
and plan mechanistic investigations of microbiome-health links in ageing humans.
The gut microbiome and sedentary life-style disorders in Homo sapiens
The link between an altered gut microbiome and obesity was one of the earliest and most 
dramatic microbiome-disease links postulated [83]; unfortunately it is also one of the most 
complex [84, 85]. The first concept of how gut microbes might affect obesity centred on energy 
harvest from the diet by a microbiota enriched for phylum Firmicutes [86], which seemed be 
corroborated by microbiome alterations associated with weight loss during caloric restriction [87]. 
However other studies failed to replicate such simplistic microbiome remodelling with obesity 
[88], and there are now at least four microbiome-related mechanisms that probably contribute to 
obesity including calorie harvesting/energy metabolism, gut barrier function and inflammatory 
effects on adipogenesis, satiety and insulin resistance, and altered bile acid signalling [85]. This 
makes the task of finding a unifying microbiota signature for obesity very challenging [89], coupled 
with small sample size and lack of power that was a feature of many early studies [90].
Some obese subjects suffer also from impaired glucose metabolism [91] or metabolic 
syndrome, a spectrum of metabolic defects that respond to some degree to faecal microbiota 
transplantation [92]. Attempts to identify microbiota alterations for type 2 diabetes (T2DM) have 
been less consistent that obesity [93-95], due in part to the confounding effects of metformin that 
is very commonly used to treat T2DM [24].
Animal models have been useful in exploring microbial taxa and mechanisms involved in 
obesity and metabolic disorders. The ob/ob leptin deficient mouse was used to demonstrate the 
transmissibility of the obesity phenotype within germ-free mice [83], and in many follow up 
investigations. Various rodent (primarily mouse) transfer experiments [96] have also been 
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variable success of human microbiota engraftment in wild-type or antibiotic treated mice, and the 
inflammatory response of germ-free mice to faecal transfer [97], complicate the interpretation of 
these experiments.
Animal models for microbiome and the diseasome of ageing
Human evolution has led to a basic physiology adapted to seasonal variation in both food type and 
availability, coupled with the development of an upward stance, bipedal gait and range mobility. 
Epigenetic regulation of metabolism has facilitated dynamic responses to changes in nutrient 
availability under such circumstances. Modern humans, however, have rapidly developed a 
capacity for sedentary living within an energy dense environment. A consequence of this is an 
increasing prevalence of obesity and associated metabolic sequelae, including T2DM, 
hypertension, fatty liver disease and chronic kidney disease and a range of cardiometabolic 
disorders [39, 98, 99]. Additionally, the human diet is atypical for the evolutionary development of 
the gut. Man is an omnivore, with dentition and a gut adapted from frugivorous primate ancestors 
for digestion of a wide range of plant-based protein. However, the modern Western diet, is 
excessively energy-rich and has a disproportionately large intake of red meat [100]. This skewing 
towards a more carnivorous diet has resulted in a dietary association with the diseasome of 
ageing. Excess red meat consumption has been linked with hyperphosphataemia, renal 
dysfunction and cancer [101, 102], while reduced fruit and vegetable intake has been associated 
with microbiome changes, poorer physiological resilience and adverse cardiovascular health [103].
Pre-clinical modelling of the impact of the microbiome on human health is fraught with the 
danger of artefact and error [104]. This stems from both inadequate mammalian models for 
human health and differences in microbial diversity between species. However, murine models 
while typically best fits for conditions of human health, share not only the hallmarks of ageing, but 
also common mammalian elements of ageing, such as hyperphosphataemia and inflammageing. 
Despite differing life strategies, murine models have proven invaluable in dissecting metabolic 
disorders and ageing. Additionally, they have the advantage of being able to be produced in germ 
free conditions, to enable more subtle understanding of the impact of the microbiome on human 
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Significant manipulation of the microbiome in models of accelerated ageing has yet to be 
undertaken, though one obvious choice for such an investigation is the klotho mouse [105]. The 
klotho gene encodes a transmembrane protein that acts as an obligatory co-receptor for FGF23, a 
regulator of phosphate metabolism. Mutation in klotho results in progeria and an associated 
range of features common to the diseasome of ageing, including renal dysfunction, 
neurodegeneration, vascular dysfunction, arteriosclerosis, sarcopaenia, osteoporosis [106]. What 
such models do not address with respect to human health is the impact of a sedentary lifestyle 
and inter-individual variation in response to differences in nutrition [56].
While providing rodents with calorie excess can cause obesity and generate pathogenic 
sequelae, they do not recreate the aetiopathogenesis of human sedentary associated disease. The 
human exposome, for example, and its influence on disease predisposition and progression, is not 
captured by standard laboratory models. The exposome will undoubtedly have species specific 
effects engendered on different species living in the same physical environment. The level of 
psychosocial stress within that environment has a direct impact on both ageing and adiposity in 
man [43] and would thus be expected to have a similar impact on any model organism and to be 
reflected in differential epigenomic effects (e.g. methylation patterns). Notably exposome changes 
radically affect gut microbiota [107].
A range of epidemiological studies have indicated that dietary risk factors in humans have 
distinct genetics associated with them and that the gut microbiome differs in response to the 
same diet in obsess and lean individuals. Translating this from a rodent model, where intra-strain 
differences have substantial metabolic differences is challenging to say the least [108]. One 
possible solution is to investigate common genera/OTUs associated with underlying ageing 
processes and how these interplay with the epigenome of ageing in response to dietary variation. 
By this means one can then link environmental differences (i.e. nutrition) to age related changes in 
health.
Nonetheless, microbial transplantation studies in rodent models have generated exciting 
data that modulation of microbiota may improve management of Type I diabetes (T1DM) [109].  
Notwithstanding the caveats outlined above, rodent studies have implicated Bacteroides spp. as a 
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Microbial transplantation from obese humans to lean mice has been demonstrated to 
confer obesity on recipient animals [110]. This has also been observed in xenotransplantation of 
pre-hibernation bear microbiota to germ free mice, resulting in the recipients becoming obese 
and torpid [111]. Non-human primates are more closely related both physiologically and 
genetically to humans than other model organisms, but their use is complicated by a range of 
concerns including cost, the time it takes to do meaningful studies and relatively low subject 
numbers. They are, however, a critical translational bridge going from small animal preclinical 
models to human clinical trials. Non-human primates are prone to the development of obesity and 
a range of associated comorbidities, but in the wild this is rare due to their levels of physical 
activity and a diet that is rarely in energy excess. When fed a high fat, and, or a high sugar diet, 
they develop adiposity, diabetes and a range of adverse cardiometabolic features, including 
hypertension [49, 112, 113]. Strikingly, captive primates develop a ‘humanized microbiome [107] 
possibly linked with a shift in diversity or types of dietary polysaccharides.
As such, the change in exposome in going from the wild to captivity, or being reared in 
captivity, bears a striking parallel to the increasing prevalence of cardio-metabolic disorders in 
modern man and the effect of mass human migration and Western diet on the composition of the 
human microbiome, As such, non-human primate model may represent a ‘gold standard  for 
assessing the impact of the microbiome on human health span. It is notable, that with the 
humanisation of captive primate microbiomes, comes a correlation with the appearance of 
cardiovascular disease and psychopathologies not typically observed in their wild counterparts 
[114, 115]. 
One aspect of human health not typically covered by traditional preclinical models is the 
impact of hospital stays in Intensive treatment units, where the patient is bed bound and often 
subject to ex vivo support for organ function. The consequence of such prolong intensive support 
is loss of bone and muscle mass and eventual organ failure. These features are not observed in 
hibernating mammals, such as the brown bear [44], which is able to preserve muscle and bone 
mass during several months of hibernation. Critical to this is a dynamic microbiome [111]. The 
composition of the bear microbiome alters seasonally as the bears prepare for hibernation, 
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accumulation. Germfree mice colonized with bear microbiota adapted the seasonal physiological 
characteristics of the bear, clearly indicating a role of the microbiome in physiological obesity.
No mention of models of ageing can go without discussion of the naked mole-rat (NMR). 
The NMR has a lifespan exceeding 30 years and appears to defy Gompertzian laws, as their 
mortality rate does not increase with age [116]. They are resistant to neoplasia and oxidant stress, 
display minimal changes in age-related physiological function or tissue deterioration and remain 
reproductively active throughout their lifespan. The composition of their gut microbiome appears 
to reflect their subterranean existence and is rich in bacteria able to use soil sulphate as a terminal 
electron acceptor for anaerobic oxidative metabolism [117]. Notably, their microbiome shares 
features with human centenarians and Hadza hunter-gatherers, which have been proposed as 
models for a human gut microbiome relative to normative ageing processes, including a high load 
and diversity of Spirochetaceae and the presence of Mogibacteriaceae. Significantly, NMRs exhibit 
an enhanced capacity to produce short chain fatty acids associated with reduced colonic 
inflammation. Additionally, they have an enhanced capacity for production of mono- and 
disaccharides, which may aid in fructolysis in an oxygen deprived environment and enable 
resistance to oxygen deprivation.
Knowledge gaps and key future experiments
While animal models undoubtedly provide critical insight into disease pathogenesis and offer 
application for experimentation impossible for conventional human studies [118], they typically 
involve laboratory rodents that are metabolically morbid and lacking appropriate features of 
either human pathogenesis or normative ageing [119, 120]. Such models are sedentary, obese and 
glucose intolerant, which while appropriate for the study of human obesity, or aspects of 
metabolic syndrome, such as T2DM, they still exhibit a poor correlation with the human disease 
[110]. This is also observed for hypertension, which is now the most common disease globally 
[120]. Recently, however, a mini pig model has been described which more closely described the 
human pathogenesis of metabolic syndrome, inclusive of  adipose tissue inflammation and 
adipocyte necrosis, not see in other rodent models [121]. This is encouraging, but still has a 
fundamental flaw, in that captivity will alter its co-evolved commensal microbiome, as has been 
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microbiome in response to available food stuffs in the wild.  As such, the best model for the study 
of humans remains human subjects.
However, looking more widely in the animal kingdom, hibernating species and microbiome 
dynamics associated with significant metabolic reprogramming necessary to maintain health 
during periods of hibernation, offer excellent models to study the impact of nutrition on the 
microbiome and how this is linked to physiological function. This is exemplified by the Brown bear 
and the Giant Panda. Notably, gut microbial transition also occurs in Pandas translocated from 
captivity to wild habitat and has a direct bearing on the survival of this species. Understanding any 
relationship between the symbiotic gut microbiome and host environmental adaptation in this 
context, is not only important for the species survival and conservation, but offers a novel model 
system for insights into the underpinning molecular mechanisms in a normative (or near 
normative) environment [122]. How this will translate to human exposome differences related to 
health span remains to be determined.
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Figure legends
Figure 1. Methods for studying the microbiome and associated read-outs.
Exposome factors modulate the micorboiome in older sedentary humans, in turn directly 
modualring factors regualting health span
Figure 2. Schematic representation of the bidirectional interaction of the human gut microbiome 
with external factors that it is modulated by, and host systems that it may influence. The challenge 
is to identify natural animal systems that emulate these interactions, or model systems where 
they can be manipulated to explore mechanisms
Figure 3. Interaction between environmental modifiers, the microbiome, and health 
The exposome represents the geophysical and social environments of an individual across their 
lifecourse. This has a direct impact on an individual’s microbiome, particularly via the composition 
and calibre of the foodome.  A sub-optimal foodome can lead to an aberrant microbiome with 
consequential health effects, typically mediated by accelerated ageing, whereby the hallmarks of 
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